… in lung macrophages by Raman spectroscopy. … that iron oxide particles enhanced the
activation of lung type 2 innate lymphoid cell in the presence of antigen. Meanwhile, our in vitro …

… of cancers either in vitro using biopsy and blood samples or in vivo through direct injection
… a confinement effect preventing physical interaction among the formed particles within …

… in vivo, but their cytotoxicity in vivo is not yet apparent. As most of the NPs applied in vivo are
captured and metabolized by macrophages… basis for studying the cytotoxicity of NPs in vivo. …

… ) because of their great magnetic properties and that iron is naturally occurring in vivo.
Nanoparticles (NPs) of Gadolinium oxide have been investigated for MR contrast enhancement (…

… as a lung cancer treatment to reduce toxicity in vitro and in vivo; in … The peak analysis also
showed the interaction of the drug … -induced lung carcinoma using LLY-507-loaded iron oxide …

… Both iron oxide-based nanoparticles (Fe 3 O 4 NPs) for magnetic resonance imaging (MRI)
and radiotracers for positron emission tomography (PET) have shown potential as in vivo cell …

… areas, leading to multivalent interactions with immune cells, … we investigated the in vitro
effects of iron oxide NPs as immune … inhibitory cytokines, called IL-10 by macrophages cells. …

… Only the uncoated maghemite iron oxide nanoparticles demonstrated maximum interaction
… A summary of bare and surface-modified iron oxide MNPs’ in vitro and in vivo toxicity has …

… HA-SPIONs showed significant cell uptake and could be rapidly internalized into cancer cells
in vitro mainly thanks to the ligand–receptor interaction between HA and CD44. They found …

… combined and in which iron oxide nanoparticles are used, are image-… iron oxide nanoparticles,
and indicate the integration in future medical practice of multiple iron oxide nanoparticle…